On this page, you will find information about a genetic change that was identified in a UDN participant. We are trying to find others with the same or similar condition.
Sharing information on this website is not a requirement of UDN participation. Only descriptions about participants who give explicit consent will appear here.
A change in the ALG2 gene was identified in a male, age 7, with global developmental delay, muscle weakness, hand tremor, increased tone in lower limbs (hypertonia), and facial differences (read full description).
Apr 08, 2021
alpha-1,3/1,6-mannosyltransferase
The ALG2 gene codes for alpha-1,3-mannosyltransferase, which is involved in the N-linked glycosylation pathway and have been associated with myasthenic syndromes (Cossins et al., 2013).
A change in this gene was identified in a UDN participant. Research is underway to see if this change is causing symptoms in this participant.
Interested in learning more about this gene or sharing what you know? Contact us!